Key takeaways
- Freeze-drying has three stages: freezing, primary drying (sublimation under vacuum) and secondary drying (removing bound water).
- Dry is more stable, not frozen in time: deamidation, oxidation and aggregation can still happen in the solid, faster with heat and moisture.
- A small, uneven or film-like cake is not necessarily a problem; visible liquid or a sticky, glassy residue deserves a question.
- Peptides are often hygroscopic. Water taken up from the air lowers the peptide content of the powder and can reduce stability.
01How does freeze-drying work?
FDA's inspection guide defines lyophilization as removing water from a product after it is frozen and placed under a vacuum, so the ice changes directly from solid to vapour without passing through a liquid phase.
The solution is frozen in the vial on cooled shelves. How fast it freezes shapes the ice crystals, and with them the pores that vapour escapes through later.
The chamber is put under vacuum and the shelves are warmed gently. Ice turns to vapour and leaves a porous solid behind. The product has to stay below the temperature at which it would soften and collapse.
Shelf temperature rises to pull off water still bound to the solid. What remains is residual moisture, which the process aims to keep low.
FDA notes that the process adds handling time and needs complex, costly equipment. It lists its advantages as enhanced stability of a dry powder, removal of water without excessive heating, and rapid dissolution when the product is reconstituted.
02Why are peptides supplied as a powder?
A dry solid is more stable than a solution. In water, peptides slowly break down. Peptide manufacturer Bachem advises that peptides should not be stored in solution, and that solutions may slowly undergo chemical degradation. Taking the water out slows most of those reactions down.
It does not stop them. A 1999 review of solid-state chemical stability lists the reactions that continue in dry peptides and proteins: deamidation, peptide bond cleavage, oxidation, the Maillard reaction, beta-elimination, and dimerisation or aggregation. The main factors are temperature, moisture content, excipients, and whether the solid is amorphous or crystalline.
Dry and cold slow the clock. They do not stop it, which is why storage conditions after delivery matter. See peptide storage.
03What can a lyophilized peptide cake look like?
The dried solid in a vial is called the cake. In pharmaceutical manufacturing the ideal is a uniform, elegant cake, but a 2017 industry commentary on cake appearance notes that a non-ideal appearance sometimes has no impact on product quality and can be inherent to the formulation, the vial and the process.
Not necessarily a problem
A small pellet, a thin film on the glass, a cracked or shrunken cake, or loose powder that has moved in transit. With only a few milligrams in a vial, there may not be much to see.
Worth a question
Visible liquid, or a sticky, glassy residue. FDA describes meltback, a form of collapse from incomplete sublimation, as linked to a pocket of moisture and greater instability.
What looks can't tell you
Identity, purity, amount or endotoxin. A perfect cake can hold the wrong peptide; only the lab report answers that.
04Why does moisture matter for lyophilized peptides?
Bachem describes peptides as tending to be hygroscopic: they pull water from the air. It notes that moisture absorption reduces the overall peptide content and may also decrease stability.
That matters twice. First, the weight of a powder is never all peptide: it also holds counter-ions such as acetate or trifluoroacetate, plus residual moisture. That is the gap between gross weight and net peptide content. Second, water is one of the drivers of solid-state degradation.
- Keep vials sealed until needed.
- Let a cold vial reach room temperature before opening; manufacturers advise doing this in a desiccator, so condensation does not form on the solid.
- Weigh quickly and re-seal.
- Repeatedly opening a cold vial in humid air.
05How stable is a peptide before and after reconstitution?
| State | Main risks | General manufacturer guidance |
|---|---|---|
| Lyophilized solid, sealed | Slow solid-state reactions; faster with heat and moisture | Tightly closed container below −15 °C for longer storage (Bachem) |
| In solution | Faster chemical degradation; oxidation of Cys, Met and Trp; deamidation at Asn and Gln | Long-term storage in solution not recommended; aliquot and keep frozen below −15 °C; frozen solutions may keep for a few weeks (Bachem) |
These are general statements about laboratory material. How long a given peptide stays within specification depends on its sequence, the solvent, pH, temperature and handling. This page describes laboratory handling only and gives no instructions for use in people.
06What don’t we know about peptide stability?
For approved peptide medicines, manufacturers run formal stability studies on their own formulation. For most research-grade peptides we have not found published, sequence-specific stability data, so shelf-life statements are usually extrapolated from general guidance rather than measured.
If a vial has been stored for a long time, or stored badly, the way to know where it stands is a fresh test, usually HPLC for purity and mass spectrometry for identity.
Plain-English summary of FDA and manufacturer technical sources, checked 17 November 2026. Not legal or medical advice.